VFA
AMPE

Virtus Fund Advisers’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Virtus Fund Advisers’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-12
Closed -$29K – 2109
2014
Q2 		$29K Buy
+12
New +$24.5K ﹤0.01% 2229

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Virtus Fund Advisers's AMPE Position: Q3 2014 in Review

Virtus Fund Advisers sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2014, closing a stake of 12 shares — an estimated $29K sold.

Virtus Fund Advisers first reported a position in AMPE in Q2 2014 and held it in 1 quarter. The position peaked at $29K in Q2 2014. 80 funds tracked by Wall St. Rank hold AMPE as of Q3 2014.

  • Virtus Fund Advisers reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 12 Ampio Pharmaceuticals Inc. shares in Q3 2014, an estimated $29K.
  • Virtus Fund Advisers first reported a position in Ampio Pharmaceuticals Inc. in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's Ampio Pharmaceuticals Inc. position peaked at $29K in Q2 2014.
  • 80 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.